Seroprevalence of cytomegalovirus, hepatitis B, hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors

Iranian Journal of Public Health

Volumn 33, Issue 4, 2004, Pages 38-42

  Moniri, R ^a   Mosayebii, Z ^a   Mossavi, G A ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donors; CMV; Hepatitis B; Hepatitis C; HIV; Iran; Seroprevalence

Indexed keywords

EID: 67649242133     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dodd RY (1994). Adverse consequences of blood transfusion: quantitative risk estimates. In: Nance ST, Ed. Blood supply: risk, perceptions and prospects for the future. Bethesda, Md.: American Association of Blood Banks, PP: 1-24.
2. Kleinman S (1992). Donor selection and screening procedures. In: Nance ST, Ed. Blood safety: current challenges. Bethesda, Md.: American Association of Blood Banks, PP: 169-200.
3. Alter HJ (1995). To C or not to C: these are the questions. Blood, 85: 1681-85.
4. Aach RD, Szmuness W, Mosley JW et al (1981). Serum alanine amino transferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the Transfusion-Transmitted Viruses Study. N Engl J Med, 304: 989-94.
5. Donegan E, Stuart M, Niland JC et al (1990). Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med, 113: 733-39.
6. Nelson KE, Donahue JG, Munoz A et al (1992). Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery: a multi center study of HIV-1 and HTLV-I/II infections. Ann Intern Med, 117: 554-59.
7. Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE (1981). Donor transaminase and recipient hepatitis: impact on blood transfusion services. JAMA, 246: 630-34.
8. Alter HJ, Epstein JS, Swenson SG et al (1990). Prevalence of human immunodeficiency virus type 1 p24 antigen in US blood donors an assessment of the efficacy of testing in donor screening. N Engl J Med, 323: 1312-17.
9. Busch MP, Eble BE, Khayam-Bashi H, et al (1991). Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med, 325: 1-5.
10. Kleinman S, Alter H, Busch M, et al (1992). Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion, 32: 805-13.
11. Aach RD, Stevens CE, Hollinger FB, et al (1991). Hepatitis C virus infection in post-transfusion hepatitis-an analysis with first-and second-generation assays. N Engl J Med, 325: 1325-29.
12. Amini S, Mahmoodi MF, Andalibi S, Solati AA (1993). Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: A population based study. J Trop Med Hygiene, 96: 277-87.
13. EbrahimPoor S, Yaghoobi M, Gharamaleki V et al (1997). Seropidemiological studies of hepatitis B and C in haemophiliacs in northwestern Iran. Irn J Med Sci, 22: 126.
14. Karimi M and Ghavami AA (2001). Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health, 37: 564-66.
15. Nabavizadeh SH, Haghbeen S (1379). Prevalence of transmitted infection in donors of Yasuji Blood Transfusion Organization. Journal of Medical Faculty Guilan University of Medical Sciences, 35-36 (9): 64-7.
16. Sadeghi A, Shariatzadeh MR, Lamei A (1377). Evaluation of hepatitis C virus (HCV) among blood donors in Urmia Transfusion Center. Urmia Medical Journal, 4(9): 242-48.
17. Afzali H, Taghavi Ardakani A, Vali G R (1381). Seroepidemiology of hepatitis B and C in blood donors in Kashan, 1996-2001. Feyz, 23 (6): 43-50.
18. Radjaii Oskui M (1373). Study of CMV infection in 200 blood donors of national blood Transfusion Center of Tabriz. Medical Journal of Tabriz University of Medical Sciences & Health Services, 28(23): 41-6.
19. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996). The Risk of Transfusion-Transmitted Viral Infections. N Engl J Med, 334: 1685-69.
20. Schmuñis GA, Zicker F, Segura EL, del Pozo AE (2000). Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion, 40(9): 1048.